» Authors » H Yagi

H Yagi

Explore the profile of H Yagi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 493
Citations 4657
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Abe K, Kitago M, Matsuda S, Shinoda M, Yagi H, Abe Y, et al.
Surg Case Rep . 2022 Dec; 8(1):220. PMID: 36484868
Background: Follicular dendritic cell sarcoma is a rare stromal tumor with no standard treatment. However, some reports have revealed that follicular dendritic cell sarcoma has an inflammatory pseudotumor variant associated...
2.
3.
Sano Y, Moriki M, Yagi H, Tokura Y
J Eur Acad Dermatol Venereol . 2019 Feb; 33(4):e164-e166. PMID: 30779231
No abstract available.
4.
Wakabayashi T, Shinoda M, Obara H, Kitago M, Yagi H, Abe Y, et al.
Transplant Proc . 2018 Dec; 50(10):3626-3634. PMID: 30577248
Background: Sarcopenia has recently been studied as a potential risk factor for mortality and complications after liver transplantation. We investigated the impact of low muscle mass on postoperative outcomes after...
5.
Takamatsu H, Takezako N, Zheng J, Moorhead M, Carlton V, Kong K, et al.
Ann Oncol . 2017 Sep; 28(10):2503-2510. PMID: 28945825
Background: Most patients with multiple myeloma (MM) are considered to be incurable, and relapse owing to minimal residual disease (MRD) is the main cause of death among these patients. Therefore,...
6.
Yagi H, Asanoma K, Ohgami T, Ichinoe A, Sonoda K, Kato K
Oncogene . 2016 Jan; 35(34):4471-80. PMID: 26804165
G-protein-coupled receptors (GPCRs) and their ligands function in the progression of human malignancies. Gα12 and Gα13, encoded by GNA12 and GNA13, respectively, are referred to as the GEP oncogene and...
7.
Collin de lHortet A, Takeishi K, Guzman-Lepe J, Handa K, Matsubara K, Fukumitsu K, et al.
Am J Transplant . 2015 Dec; 16(6):1688-96. PMID: 26699680
Liver transplantation, either a partial liver from a living or deceased donor or a whole liver from a deceased donor, is the only curative therapy for severe end-stage liver disease....
8.
Tokura Y, Yagi H, Yanaguchi H, Majima Y, Kasuya A, Ito T, et al.
Br J Dermatol . 2014 Jul; 171(5):959-67. PMID: 25065694
IgG4-related disease (IgG4-RD) is a recently established clinical entity characterized by high levels of circulating IgG4, and tissue infiltration of IgG4(+) plasma cells. IgG4-RD exhibits a distinctive fibroinflammatory change involving...
9.
Shinoda M, Tanabe M, Itano O, Obara H, Kitago M, Abe Y, et al.
Transplant Proc . 2014 Jun; 46(5):1400-6. PMID: 24935304
Background: We present our attempts at reducing the length of incision in living donor left-side hepatectomy without laparoscopic approach. Methods: The chief surgeon initially made a 10-cm upper midline incision...
10.
Nishiyama R, Shinoda M, Tanabe M, Oshima G, Takano K, Miyasho T, et al.
Eur Surg Res . 2014 Jan; 51(3-4):181-90. PMID: 24434684
Background: High-mobility group box chromosomal protein 1 (HMGB1) has recently been identified as an important mediator of various kinds of acute and chronic inflammation. A method for efficiently removing HMGB1...